Sun Pharmaceutical Industries Ltd.

SUNPHARMA

INE044A01036

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 06:49:12 2025-12-10 am EST			5-day change	1st Jan Change
1,785.50 ^INR	+0.53%		-1.17%	-5.35%

Dec. 03	Novo Nordisk gears up for December Ozempic launch in India, sources say	RE
Dec. 01	Sun Pharmaceutical Launches Plaque Psoriasis Drug in India	MT

Sun Pharmaceutical Industries Names Jayashree Satagopan As CFO

Published on 05/06/2025 at 10:09 am EDT

Reuters

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Sun Pharmaceutical Industries Ltd.

Dec. 03	Novo Nordisk gears up for December Ozempic launch in India, sources say	RE
Dec. 01	Sun Pharmaceutical Launches Plaque Psoriasis Drug in India	MT
Nov. 30	Sun Pharma introduces Ilumya in India	RE
Nov. 28	Indian Equities Ended Flat on Friday Ahead of Q2 GDP Data	MT
Nov. 26	Sun Pharma says FDA approves label update for Unloxcyt	RE
Nov. 25	Sun Pharmaceutical Industries Limited Announces Updated Label for Unloxcyt?	CI
Nov. 17	AstraZeneca Pharma India, Sun Pharma Sign Second Brand Deal for SZC in India	MT
Nov. 17	Astrazeneca Pharma India and Sun Pharma partner for hyperkalaemia treatment	RE
Nov. 17	AstraZeneca Pharma India Limited and Sun Pharmaceutical Industries Limited Announce Partnership to Help Patients Living with Hyperkalaemia in India	CI
Nov. 12	Sun Pharma presents data from phase 1b/2a study of GL0034	RE
Nov. 12	Sun Pharma says once weekly utregrlutide dosing for ten weeks showed body weight loss of 6.8%	RE
Nov. 12	Sun Pharmaceutical Industries Limited Presents Data from Phase 1b/2a Study of GL0034 at the American Heart Association 2025 Scientific Sessions	CI
Nov. 07	India's Torrent Pharma posts profit boost on strong demand for chronic illness drugs	RE
Nov. 07	Nomura Upgrades Sun Pharmaceutical Industries to Buy From Neutral, Adjusts Price Target to INR1,960 From INR1,910	MT
Nov. 06	Sun Pharmaceutical's Consolidated Net Profit Rises in Fiscal Q2	MT
Nov. 06	Jefferies Adjusts Sun Pharmaceutical Industries' Price Target to INR2,000 From INR2,070, Keeps at Buy	MT
Nov. 05	India equity benchmarks open higher as stronger earnings, MSCI rejig lift sentiment	RE
Nov. 05	Sun Pharmaceutical Industries Limited, Q2 2026 Earnings Call, Nov 05, 2025
Nov. 05	India's Sun Pharma exec says open to considering (expanding) manufacturing presence in the U.S.	RE
Nov. 05	Sun Pharmaceutical Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
Nov. 05	Sun Pharma Q2 consol net PAT 31.18 bln rupees	RE
Nov. 05	India's Sun Pharma beats Q2 profit estimates, targets growth through drug launches	RE
Oct. 08	Sun Pharma - NCLT approves amalgamation of units Sun Pharmaceutical Medicare, others with co	RE
Oct. 01	Technical Analysis: Sun Pharmaceutical steadies at a crucial support
Sep. 26	Indian pharma stocks fall after Trump's new drug tariffs; mostly 'sentimental', say analysts	RE

Chart Sun Pharmaceutical Industries Ltd.

Duration

Period

Chart Sun Pharmaceutical Industries Ltd.

SUNPHARMA: Dynamic Chart

Sun Pharmaceutical Industries Ltd. is one of the Indian leaders of pharmaceutical groups. Net sales break down by family of products as follows: - generic and OTC medicines (94%): for cardiologic, psychiatric, neurological, gastroenterological, diabetic and respiratory diseases treatment; - other (6%) : primarily active pharmaceutical ingredients. At the end of March 2021, the group had 44 production plants worldwide. Net sales are distributed geographically as follows: India (33%), the United States (31.3%), other (35.7%).

Employees

43,000

Sector

Pharmaceuticals

Calendar

Feb. 03 - Q3 2026 Earnings Release (Projected)

More about the company